Cargando…
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy
Resistant tumours are thought to arise from the action of Darwinian selection on genetically heterogenous cancer cell populations. However, simple clonal selection is inadequate to describe the late relapses often characterising luminal breast cancers treated with endocrine therapy (ET), suggesting...
Autores principales: | Hong, Sung Pil, Chan, Thalia E., Lombardo, Ylenia, Corleone, Giacomo, Rotmensz, Nicole, Bravaccini, Sara, Rocca, Andrea, Pruneri, Giancarlo, McEwen, Kirsten R., Coombes, R. Charles, Barozzi, Iros, Magnani, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718416/ https://www.ncbi.nlm.nih.gov/pubmed/31477698 http://dx.doi.org/10.1038/s41467-019-11721-9 |
Ejemplares similares
-
Acquired CYP19A1 amplification is an early specific mechanism of
aromatase inhibitor resistance in ERα metastatic breast
cancer
por: Magnani, Luca, et al.
Publicado: (2017) -
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer
por: Patten, Darren K., et al.
Publicado: (2018) -
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
por: Nguyen, Van T. M., et al.
Publicado: (2015) -
Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
por: Nguyen, Van T. M., et al.
Publicado: (2019) -
Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells
por: Lombardo, Ylenia, et al.
Publicado: (2014)